JP2022510736A5 - - Google Patents
Info
- Publication number
- JP2022510736A5 JP2022510736A5 JP2021554804A JP2021554804A JP2022510736A5 JP 2022510736 A5 JP2022510736 A5 JP 2022510736A5 JP 2021554804 A JP2021554804 A JP 2021554804A JP 2021554804 A JP2021554804 A JP 2021554804A JP 2022510736 A5 JP2022510736 A5 JP 2022510736A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- ring
- substituted
- atom
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024102161A JP2024123202A (ja) | 2018-12-05 | 2024-06-25 | 大環状化合物とその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018228234 | 2018-12-05 | ||
| JP2018228234 | 2018-12-05 | ||
| PCT/JP2019/048593 WO2020116660A1 (en) | 2018-12-05 | 2019-12-04 | Macrocyclic compound and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102161A Division JP2024123202A (ja) | 2018-12-05 | 2024-06-25 | 大環状化合物とその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022510736A JP2022510736A (ja) | 2022-01-27 |
| JP2022510736A5 true JP2022510736A5 (https=) | 2022-11-30 |
Family
ID=70975488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554804A Pending JP2022510736A (ja) | 2018-12-05 | 2019-12-04 | 大環状化合物とその使用 |
| JP2024102161A Pending JP2024123202A (ja) | 2018-12-05 | 2024-06-25 | 大環状化合物とその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024102161A Pending JP2024123202A (ja) | 2018-12-05 | 2024-06-25 | 大環状化合物とその使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11518763B2 (https=) |
| EP (1) | EP3890738A4 (https=) |
| JP (2) | JP2022510736A (https=) |
| KR (1) | KR102919982B1 (https=) |
| CN (1) | CN113164468A (https=) |
| AR (1) | AR117251A1 (https=) |
| AU (1) | AU2019391942B2 (https=) |
| BR (1) | BR112021010704A2 (https=) |
| CA (1) | CA3121952C (https=) |
| CL (1) | CL2021001451A1 (https=) |
| CO (1) | CO2021007304A2 (https=) |
| MX (1) | MX2021006527A (https=) |
| NZ (1) | NZ776102A (https=) |
| PH (1) | PH12021551262A1 (https=) |
| SG (1) | SG11202105125XA (https=) |
| TW (1) | TWI820266B (https=) |
| UA (1) | UA127872C2 (https=) |
| WO (1) | WO2020116660A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE065501T2 (hu) | 2018-08-20 | 2024-05-28 | Janssen Pharmaceutica Nv | A KEAP1-NRF2 protein-protein kölcsönhatás inhibitorok |
| MX2021014680A (es) | 2019-05-31 | 2022-04-06 | Ube Corp | Derivado de benzotriazol. |
| WO2022056448A1 (en) * | 2020-09-14 | 2022-03-17 | Sanofi | Tetrahydroisoquinoline derivatives for the treatment of red blood disorders and inflammatory diseases |
| EP4688779A2 (en) * | 2023-04-03 | 2026-02-11 | Acelink Therapeutics, Inc. | Novel compounds and uses thereof |
| CN119707895B (zh) * | 2023-12-18 | 2026-03-31 | 江苏苏中药业研究院有限公司 | 一种7-甲酰基-2,3-二氢苯并呋喃-4-碳腈的制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011298091B2 (en) | 2010-08-31 | 2015-08-20 | Accure Therapeutics, S.L. | Agonists of neurotrophin receptors and their use as medicaments |
| ME03421B (me) | 2013-06-21 | 2020-01-20 | Karyopharm Therapeutics Inc | 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba |
| KR102301867B1 (ko) * | 2013-12-18 | 2021-09-15 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Nrf2 조절제 |
| EP3766878B1 (en) | 2015-06-15 | 2022-03-16 | GlaxoSmithKline Intellectual Property Development Limited | Nrf2 regulators |
| SI3782996T1 (sl) | 2015-06-15 | 2024-06-28 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 regulatorji |
| CA2988373A1 (en) | 2015-06-15 | 2016-12-22 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 regulators |
| US10201531B2 (en) | 2015-08-12 | 2019-02-12 | Mochida Pharmaceutical Co., Ltd. | Indazolyl-oxo-isothiazole compounds |
| WO2017060855A1 (en) | 2015-10-06 | 2017-04-13 | Glaxosmithkline Intellectual Property Development Limited | Arylcyclohexyl pyrazoles as nrf2 regulators |
| US10364256B2 (en) | 2015-10-06 | 2019-07-30 | Glaxosmithkline Intellectual Property Development Limited | Biaryl pyrazoles as NRF2 regulators |
| EP3551621A1 (en) | 2016-12-12 | 2019-10-16 | GlaxoSmithKline Intellectual Property Development Limited | N-aryl pyrazoles as nrf2 regulators |
| WO2018109641A1 (en) | 2016-12-12 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | 3-carboxylic acid pyrroles as nrf2 regulators |
| JP2020502136A (ja) | 2016-12-14 | 2020-01-23 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | Ｎｒｆ２レギュレーターとしてのビスアリールアミド |
| JP2020502123A (ja) | 2016-12-14 | 2020-01-23 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | Ｎｒｆ２アクチベーターとしてのビスアリール複素環 |
| EP3555068B1 (en) | 2016-12-14 | 2020-12-02 | GlaxoSmithKline Intellectual Property Development Limited | 3-oxo-1,4-diazepinyle compounds as nrf2 activators |
| US11059816B2 (en) | 2016-12-15 | 2021-07-13 | Glaxosmithkline Intellectual Property Development Limited | Ether linked triazoles as NRF2 activators |
| CA3044773A1 (en) | 2016-12-15 | 2018-06-21 | Glaxosmithkline Intellectual Property Development Limited | Nrf2 activators |
| AR110590A1 (es) | 2016-12-27 | 2019-04-10 | Biogen Ma Inc | Activador de nrf2 |
| US20190389836A1 (en) * | 2017-01-30 | 2019-12-26 | Biogen Ma Inc. | Nrf2 activator |
| WO2018140738A1 (en) | 2017-01-30 | 2018-08-02 | Biogen Ma Inc. | Nrf 2 activator |
| JP2020097526A (ja) | 2017-03-28 | 2020-06-25 | 武田薬品工業株式会社 | 複素環化合物 |
-
2019
- 2019-12-04 NZ NZ776102A patent/NZ776102A/en unknown
- 2019-12-04 EP EP19892751.9A patent/EP3890738A4/en active Pending
- 2019-12-04 CN CN201980080214.5A patent/CN113164468A/zh active Pending
- 2019-12-04 AR ARP190103549A patent/AR117251A1/es unknown
- 2019-12-04 US US17/299,659 patent/US11518763B2/en active Active
- 2019-12-04 WO PCT/JP2019/048593 patent/WO2020116660A1/en not_active Ceased
- 2019-12-04 AU AU2019391942A patent/AU2019391942B2/en active Active
- 2019-12-04 TW TW108144324A patent/TWI820266B/zh active
- 2019-12-04 KR KR1020217020790A patent/KR102919982B1/ko active Active
- 2019-12-04 BR BR112021010704-5A patent/BR112021010704A2/pt unknown
- 2019-12-04 UA UAA202102856A patent/UA127872C2/uk unknown
- 2019-12-04 SG SG11202105125XA patent/SG11202105125XA/en unknown
- 2019-12-04 JP JP2021554804A patent/JP2022510736A/ja active Pending
- 2019-12-04 CA CA3121952A patent/CA3121952C/en active Active
- 2019-12-04 MX MX2021006527A patent/MX2021006527A/es unknown
-
2021
- 2021-05-31 PH PH12021551262A patent/PH12021551262A1/en unknown
- 2021-06-02 CL CL2021001451A patent/CL2021001451A1/es unknown
- 2021-06-03 CO CONC2021/0007304A patent/CO2021007304A2/es unknown
-
2024
- 2024-06-25 JP JP2024102161A patent/JP2024123202A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022510736A5 (https=) | ||
| JP2021011503A5 (ja) | 製剤用脂質ナノ粒子 | |
| JP2024543976A5 (https=) | ||
| JP2012522759A5 (https=) | ||
| RU2005123802A (ru) | Производные адамантана, способы их получения и содержащие их фармацевтические композиции | |
| JP2012532883A5 (https=) | ||
| JP2019521988A5 (https=) | ||
| JP2016506916A5 (https=) | ||
| JP2015537020A5 (https=) | ||
| JP2018534348A5 (https=) | ||
| CA2506082A1 (en) | Novel medicaments for the treatment of chronic obstructive pulmonary disease | |
| RU2013140169A (ru) | Противоопухолевое терапевтическое средство | |
| JP2012505871A5 (https=) | ||
| JP2016512232A5 (https=) | ||
| JP2009531277A5 (https=) | ||
| JP2018533593A5 (https=) | ||
| JP2013542992A5 (https=) | ||
| JP2017141277A5 (https=) | ||
| JP2014505017A5 (https=) | ||
| MX2024014845A (es) | Esteroides neuroactivos no saturados 9(11) y sus metodos de uso | |
| PH12017501428A1 (en) | 4-substituted benzoxaborole compounds and uses thereof | |
| GEAP202516802A (en) | Protac chimeric compound, preparation method thereof and use thereof | |
| JP2018521056A5 (https=) | ||
| JP2020111571A5 (https=) | ||
| CA2541781A1 (en) | 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of respiratory illnesses |